Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 3/20 | 0.45 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.44 |
| ▸ | CDK4 | P11802 | 1/20 | 0.44 |
| ▸ | CCND1 | P24385 | 1/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668748 | 0.87 | CCNE2 (0.57) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL6950855 | 0.84 | CCNE2 (0.66) | GSK3BCCNE2CDK4CCND1CCNE1 | |
| SCHEMBL7499261 | 0.83 | GSK3B (0.51) | BRD4CREBBPGSK3BCCNE2CDK4 | |
| SCHEMBL7059442 | 0.83 | GSK3B (0.57) | GSK3BCCNE2CDK4CCND1CCNE1 | |
| SCHEMBL27382005 | 0.83 | BRD4 (0.44) | BRD4CREBBPCDK2 | |
| SCHEMBL7508119 | 0.82 | CCNE2 (0.56) | CCNE2CDK4CCND1CCNE1CDK2 | |
| SCHEMBL7497956 | 0.82 | GSK3B (0.57) | GSK3BCCNE2CDK4CCND1CCNE1 | |
| Enmd-981693 SCHEMBL608128 | 0.82 | CCNE2 (0.69) | GSK3BCCNE2CDK4CCND1CCNE1 | |
| SCHEMBL7506705 | 0.82 | CDK2 (0.51) | GSK3BCCNE2CDK4CCND1CCNE1 | |
| Enmd-981693 SCHEMBL29350364 | 0.82 | CCNE2 (0.69) | GSK3BCCNE2CDK4CCND1CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0915870-B1 | SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION | HOFFMANN LA ROCHE (CH) | 2002-09-25 | — | — | EP | disclosed |
| US-6228877-B1 | ANTICARCINOGENIC, ANTITUMOR AND ANTIPROLIFERATIVE AGENTS | HOFFMANN-LA ROCHE INC. | 2001-05-08 | — | — | US | disclosed |
| EP-0915870-A1 | SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION | F. HOFFMANN-LA ROCHE AG (CH) | 1999-05-19 | — | — | EP | disclosed |
| WO-1998004551-A1 | SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION | F. HOFFMANN-LA ROCHE AG (CH) | 1998-02-05 | — | — | WO | disclosed |